Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2013
Effect of pregabalin on erectile function and penile NOS expression in rats with streptozotocin-induced diabetes.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Amany S, Heba K
Аннотация
OBJECTIVES: To investigate the effect of pregabalin on erectile function and on the penile expression of nitric oxide synthase (NOS) isoforms in diabetic rat models.
METHODS: Male Sprague-Dawley rats were injected with streptozotocin to induce diabetes mellitus. The rats with blood glucose levels above 300 mg/dL were selected for the study. Those were randomly divided into 2 groups (N=10 per group): i) EDDM (erectile dysfunction diabetes mellitus) group fed with saline and ii) EDDM+Pregabalin treated group receiving pregabalin (10 mg/k/day) by intragastric administration. 10 animals served as a control group and received no streptozotocin. 4 weeks later, the erectile function of the rats was assessed by recording frequency of erection after subcutaneous apomorphine (80 ug/kg) injection. Superoxide anion generation and the expression of mRNA of nNOS and eNOS were evaluated in corpora cavernosum tissue.
RESULTS: Penile erection, the expression of both nNOS, eNOS and superoxide generation were significantly decreased in pregabalin treated group compared to control group.
CONCLUSION: Treatment with pregabalin for 4 weeks decreases superoxide production but cannot improve erectile dysfunction in diabetic rats probably by inhibiting Ca(2)(+) channel-mediated NOS activation.
METHODS: Male Sprague-Dawley rats were injected with streptozotocin to induce diabetes mellitus. The rats with blood glucose levels above 300 mg/dL were selected for the study. Those were randomly divided into 2 groups (N=10 per group): i) EDDM (erectile dysfunction diabetes mellitus) group fed with saline and ii) EDDM+Pregabalin treated group receiving pregabalin (10 mg/k/day) by intragastric administration. 10 animals served as a control group and received no streptozotocin. 4 weeks later, the erectile function of the rats was assessed by recording frequency of erection after subcutaneous apomorphine (80 ug/kg) injection. Superoxide anion generation and the expression of mRNA of nNOS and eNOS were evaluated in corpora cavernosum tissue.
RESULTS: Penile erection, the expression of both nNOS, eNOS and superoxide generation were significantly decreased in pregabalin treated group compared to control group.
CONCLUSION: Treatment with pregabalin for 4 weeks decreases superoxide production but cannot improve erectile dysfunction in diabetic rats probably by inhibiting Ca(2)(+) channel-mediated NOS activation.
Предметные рубрики MeSH
AnimalsCalcium Channel BlockersDiabetes ComplicationsDiabetes Mellitus, ExperimentalErectile DysfunctionGene ExpressionMaleNitric Oxide SynthaseNitric Oxide Synthase Type INitric Oxide Synthase Type IIIPenile ErectionPenisPregabalinRNA, MessengerRatsRats, Sprague-DawleySuperoxidesgamma-Aminobutyric Acid